Latest Form 4 insider transactions

NASDAQ
Leonard M Tannenbaum, Executive Chairman, a Director and 10% owner of Sunrise Realty Trust, Inc., purchased 50,000 shares of common stock on August 13, 2026 for $7.50 per share.
NYSE
Matthew H. Birenbaum, Chief Investment Officer of Avalonbay Communities Inc, reported multiple transactions in common stock on August 17, 2026.
NASDAQ
Steven Niemiec, Chief Revenue Officer of TechTarget, Inc., reported multiple transactions in common stock on August 13, 2026.
NASDAQ
Charles D Rennick, See Remarks of TechTarget, Inc., reported multiple transactions in common stock on August 13, 2026.
NASDAQ
William Thomas Morelli, President of TechTarget, Inc., received 63,219 shares of common stock on August 17, 2026.
NASDAQ
Daniel T Noreck, Chief Financial Officer of TechTarget, Inc., reported multiple transactions in common stock on August 13, 2026.
NYSE
M Terry Turner, a Director of Pinnacle Financial Partners, Inc., sold 174,491 shares of common stock on August 13, 2026.
NYSE
Sean J. Breslin, Chief Operating Officer of Avalonbay Communities Inc, reported multiple transactions in common stock on August 17, 2026.
Daniel Kang, Chief Strategy Officer of Janover Inc., purchased 13,000 shares of common stock on August 14, 2026 for $2.91 per share.
NASDAQ
Brandon Hetzel, CFO and Treasurer of Advanced Flower Capital Inc., purchased 1,463 shares of common stock on August 14, 2026 for $3.00 per share.
NYSE
John F Walsh, CEO-The Americas of Accenture plc, received 24 shares of common stock on August 14, 2026.
NYSE
Martin Brudermueller, a Director of Accenture plc, received 9 shares of common stock on August 14, 2026.
NYSE
Tracey Thomas Travis, a Director of Accenture plc, received 15 shares of common stock on August 14, 2026.
NYSE
Edward M Schulman, EVP-General Counsel of Avalonbay Communities Inc, reported multiple transactions in common stock on August 17, 2026.
NYSE
Melissa A Burgum, Chief Accounting Officer of Accenture plc, received 23 shares of common stock on August 14, 2026.
NYSE
Jennifer Nason, a Director of Accenture plc, received 9 shares of common stock on August 14, 2026.
NYSE
Nancy Mckinstry, a Director of Accenture plc, received 12 shares of common stock on August 14, 2026.
NYSE
Julie Spellman Sweet, Chair and CEO and a Director of Accenture plc, received 47 shares of common stock on August 14, 2026.
NYSE
Paula A Price, a Director of Accenture plc, received 14 shares of common stock on August 14, 2026.
NYSE
Katherine Lee Clifford, Chief Leadership & HR Officer of Accenture plc, sold 68 shares of common stock on August 14, 2026 for $175.97 per share.
NYSE
Catherine Kiernan Hogan, Chief Operating Officer of Accenture plc, received 50 shares of common stock on August 14, 2026.
NYSE
Sean Thomas Willson, Senior Vice President of Avalonbay Communities Inc, reported multiple transactions in common stock on August 17, 2026.
NYSE
Arun Sarin, a Director of Accenture plc, received 13 shares of common stock on August 14, 2026.
NYSE
Venkata S M Renduchintala, a Director of Accenture plc, received 9 shares of common stock on August 14, 2026.
NYSE
Manish Sharma, Chief Strategy & Services Ofcr of Accenture plc, received 17 shares of common stock on August 14, 2026.
NYSE
Matt Meeker, Executive Chairman and a Director of Bark, Inc., reported a transaction in 721 shares of common stock on August 14, 2026.
NYSE
Angie Y Park, Chief Financial Officer of Accenture plc, received 23 shares of common stock on August 14, 2026.
NYSE
Benjamin Schall, CEO & President and a Director of Avalonbay Communities Inc, reported multiple transactions in common stock on August 17, 2026.
NASDAQ
James R Tobin, a Director of TransMedics Group, Inc., reported a transaction in 18,000 shares of common stock on August 17, 2026.
NASDAQ
Troy Edward Wilson, President and CEO and a Director of Kura Oncology, Inc., purchased 100,000 shares of common stock on August 17, 2026 for $11.12 per share.